Roundup and analysis of the top headlines on health security, pandemic preparedness, COVID-19, and other news from the Johns Hopkins Center for Health Security


Please note that some links may require subscription or registration.

December 5, 2024



TOP NEWS

Confirmed human bird flu cases in US up to 58; raw milk products recalled in California; UK orders 5M human H5 influenza vaccine doses


Since our last report on November 21, the US CDC has confirmed 5 more human influenza A(H5N1) bird flu cases in California, bringing the national total to 58 in 7 states: California (32), Washington (11), Colorado (10), Michigan (2), Missouri (1), Texas (1), and Oregon (1). All but 2 of these cases are known to be related to exposure to infected cows or poultry, and all have had mild symptoms.


Raw milk recall

Raw Farm LLC of Fresno, California, this week voluntarily expanded a recall of its raw milk products due to the detection of H5N1 virus in multiple samples. The California Department of Food and Agriculture this week quarantined the farm and halted distribution of raw milk, cream, butter, and other products produced on or after November 27, warning consumers to avoid all Raw Farm products from the affected lot code 20241119 with a best by date of December 7, 2024. While no human illnesses have been linked to raw milk products to date, health authorities urge the public to avoid raw milk consumption during the outbreak. Pasteurized milk remains safe, as the pasteurization process disables the virus.


Increasing concerns

Health experts are increasingly concerned about 3 recorded human bird flu cases that have no clear link to affected poultry or dairy cattle, including a child in California, a teenager in Canada, and a patient in Missouri. These cases suggest potential unknown transmission routes or undetected animal reservoirs. While the Canadian teenager’s disease progressed to severe pneumonia and they remain hospitalized on a ventilator, all of the 58 recorded cases in the US have had mild symptoms. However, this pattern could change if the virus mutates. A study published today in the journal Science reports that it would take only a single mutation in the H5N1 strain currently circulating in dairy cattle for the virus to become more adept at attaching to human cell receptors. Public health experts and observers are also expressing concerns about potential changes in funding, staffing, or priorities for pandemic preparedness and response efforts under the new Trump administration.


“It would be important for the Trump administration, as it's rolling out its team that's going to be heading CDC, HHS, USDA, that they talk about bird flu and how their plan may differ, and how they're going to correct the deficiencies that are occurring currently.” – Amesh Adalja, MD, senior scholar with the Center for Health Security


UK buys H5 vaccine

The UK government has secured a contract for more than 5 million doses of human H5 influenza vaccine from CSL Seqirus UK Limited as part of its pandemic preparedness plans. This vaccine, based on the current H5 avian influenza strain, would only be used if the virus starts spreading among humans. The UK has not yet recorded a human case. The UK Health Security Agency (UKHSA) said the purchase is part of a broader strategy to enhance the country's readiness against a range of potential pandemic threats.


At least 67 dead in outbreak of unidentified disease in DRC; epidemiologists working to determine cause


An outbreak of an unidentified disease in the Democratic Republic of Congo (DRC) has killed at least 67 people and affected about 380 individuals, primarily in the southwestern Kwango province. Most of the deaths have been in young people aged 15 to 18, and nearly half the cases are in children under 5, with women also seriously affected, according to local experts. The illness presents as flu-like symptoms, including fever, headaches, nasal congestion, coughing, breathing difficulties, and anemia. All the fatalities happened between November 10–25, although officials said the death toll could rise as additional cases emerge.


Experts have expressed concern about the potential zoonotic origins of the disease, given the region's high interaction between humans and wildlife. But the pathogen remains unknown; epidemiological teams are collecting samples for identification and more should be known in the coming days. Congolese health officials said the government is on alert regarding the outbreak and had alerted WHO officials. Health authorities encouraged families use strict handling protocols for deceased individuals, urged the public to report unusual illnesses, and asked that they adhere to hygiene measures such as handwashing and avoiding large gatherings.


Center for Health Security Senior Scholar Caitlin Rivers, PhD, MPH, discusses how to think about disease outbreaks with no clear cause in her latest post in Force of Infection.


Mpox remains public health emergency; UK confirms fifth case of clade Ib in traveler unrelated to previous cluster


The mpox outbreak continues to be a global concern, with a second meeting of the International Health Regulations (2005) (IHR) Emergency Committee determining on November 22 that the upsurge in cases continues to constitute a Public Health Emergency of International Concern (PHEIC). The outbreak has spread to multiple countries, with cases exceeding 50,000 in Africa alone. Burundi, the Democratic Republic of Congo (DRC), and Uganda collectively account for more than 96% of all lab-confirmed cases in the region.


Prevention efforts continue

Vaccination efforts are underway in several African countries, with WHO providing technical support, adding MVA-BN (Jynneos) vaccine to its prequalification list, granting emergency use listing (EUL) for the LC16m8 vaccine, and triggering the EUL process for the ACAM2000 vaccine. However, challenges remain, including hesitation over embracing vaccinations, limited diagnostic capacity, logistical constraints, and the need to extend vaccination to children, one of the most affected demographics.


Cases outside Africa

On November 22, Canada confirmed its first imported case of clade Ib mpox, making it the seventh country outside of Africa to report a case of the novel clade first detected earlier this year in DRC. The UK, which reported its first clade Ib mpox case in October, has now reported a total of 5 cases. Four of the cases were linked to the initial case and lived in the same household. These cases represent the first locally transmitted clade Ib mpox infections in the WHO European Region and the first outside Africa.

The fifth case is a person who recently traveled to Uganda and had no links to the previous cases.


Sweden, Germany, India, Thailand, and the US have also recorded imported cases of clade Ib, but with no onward transmission to date. Still, these cases highlight the need for heightened surveillance. While the overall risk to the general public in Europe, Asia, and the Americas remain low, health systems should prepare for rapid response and urge potentially infected individuals to come forward for testing and care. 

MORE HEADLINES

WHO member states begin final pandemic agreement negotiations for 2024; observers urge nations to keep up momentum, reach consensus

Health Policy Watch: Pandemic Agreement: ‘Get it done’

Geneva Health Files: “No One Wins” A Path Towards Consensus? Positions Remain Taut in the Pandemic Agreement Negotiations


US advisory panel, expert working groups, issue brief discuss intersection of AI, biosecurity

Science: Biosecurity board mulls AI risks

NTI: NTI | bio Advances International Dialogue on AI Biosecurity Through Expert Working Groups

CSET: Anticipating Biological Risk: A Toolkit for Strategic Biosecurity Policy


Read the Center’s December 3 response to the US Artificial Intelligence Safety Institute’s (AISI) request for information (RFI) on Safety Considerations for Chemical and/or Biological AI Models.


US funding for, membership in WHO in question under new Trump administration

Politico Pulse: WHO membership on the line with Trump’s return

Politico: US membership in the World Health Organization is on the line with Trump’s return

More background: KFF: The U.S. Government and the World Health Organization


Nominations for health positions under incoming Trump administration represent views of Americans frustrated by, distrustful of COVID policies, US public health agencies

Roll Call: How backlash to the pandemic helped shape Trump’s health picks

Politico: Trump’s health nominees want Covid vindication. Here’s how their critique has aged.

New York Times: Distrustful of Health Agencies, These Voters Cheer Trump’s Picks to Run Them

CNN: One major challenge facing Trump’s chosen health leaders: Keeping politics separate from science

See also: Global Health NOW: Who Controls U.S. Public Health—the Feds or the States?


President-elect Trump nominates former congressman from Florida, physician Dave Weldon to lead CDC

NBC News: Dave Weldon, Trump's CDC pick, could bolster an RFK Jr. anti-vaccine agenda

Washington Post: Dr. Dave Weldon, Trump’s C.D.C. Pick, Was Not on Anyone’s Radar

The Guardian: ‘He is one of us!’: US anti-vaxxers rejoice at nomination of David Weldon for CDC

See also: AP: CDC chief urges focus on health threats as agency confronts political changes


US congressional subcommittee concludes 2-year after action review of COVID-19 pandemic

The Hill: Democrats, GOP lay out competing findings in COVID reports

CNN: House Covid-19 panel releases final report criticizing public health response to the pandemic

Fox News: COVID 'most likely' leaked from Wuhan lab, social distancing 'not based on science,' select committee finds

See also: Nature: Sick animals suggest COVID pandemic started in Wuhan market


US agencies drop travel advisories to level 2 for Rwanda as country goes at least 3 weeks with no new Marburg virus cases; CDC ends in-bound traveler redirection

CIDRAP: CDC lifts level 3 travel advisory for Marburg in Rwanda

Africa CDC: Africa CDC Applauds U.S. Decision to Lift Level 3 Travel Health Notice for Rwanda Following Marburg Outbreak Containment

US CDC: Traveling to the United States from Rwanda

US Department of State: Rwanda International Travel Information


Overall respiratory virus activity remains low in US but cases of RSV, flu begin to rise in some states; health experts urge more people to get vaccinated

CIDRAP: US respiratory virus activity holds steady at low levels

ABC News: Cases of RSV, flu ticking up among young children in US as respiratory virus season begins

CBS News: Are flu and COVID high now? Here's how the season has started

Washington Post: Americans are not getting seasonal vaccines ahead of the holidays

See also: The Guardian: Warning of NHS ‘quad-demic’ as flu and Covid cases rise in England


Most young people with long COVID recover within 24 months, study shows

The Guardian: Most teenagers recover from long Covid after two years, study shows

BMJ: Long covid: 70% of 11-17 year olds recover within two years, study reports

See also: CIDRAP: Air pollution may boost risk of longer-term long-COVID symptoms, research suggests


Malaria vaccination campaign begins in hard-hit Nigeria; WHO prequalifies single-dose medicine for malaria relapse prevention; new treatment research ongoing

BBC: Malaria vaccine rolled out in world's worst-affected country

GSK/Medicines for Malaria Venture: First single-dose medicine for P. vivax malaria prequalified by WHO and included in WHO Guidelines

Vox: I got malaria on purpose and so can you


Journal articles, meeting examine first outbreak of Oropouche virus in Cuba, related cases in travelers, risk of regional spread

Emerging Infectious Diseases: Reemergence of Oropouche Virus in the Americas and Risk for Spread in the United States and Its Territories, 2024

Journal of Travel Medicine: Persistent Oropouche virus viremia in two travellers returned to Italy from Cuba, July 2024 Get access Arrow

PAHO: PAHO/WHO and MINSAP Strengthen Technical Cooperation to Address Oropouche Virus Outbreak in Cuba


Global disease burden of Chikungunya higher than previously estimated, could significantly impact health systems, study warns, urges action

CIDRAP: Chikungunya moving into new regions, disabling millions and racking up billions in costs, data suggest

News Medical: Chikungunya's health and economic impact likely underestimated


Sierra Leone begins preventive Ebola virus vaccination program for frontline workers, 10 years after West Africa epidemic

The Guardian: Ten years ago Ebola tore through Sierra Leone. Can a vaccine drive stop history repeating itself?

Gavi: A decade after the deadliest Ebola outbreak in history, Sierra Leone begins a new chapter with nation-wide preventive vaccination of frontline workers


Polio remains public health emergency, IHR committee concludes at 40th meeting; virus found in sewage samples in 3 European countries

WHO: Statement of the fortieth meeting of the Polio IHR Emergency Committee

Euronews: Poliovirus has been detected in sewage in 3 European countries. What happens now?


Modern warfare contributing to proliferation of antimicrobial resistant bacterial, fungal pathogens; healthcare institutions should take proactive steps to address issue

New York Times: Modern Warfare Is Breeding Deadly Superbugs. Why?

Contagion Live: More Bugs, No Drugs: The Growing Threat of Antibiotic Resistance 


FROM THE CENTER

Panel on pandemic preparedness at Forbes Healthcare Summit / Photo credit: Cagla Giray

Center for Health Security Director Tom Inglesby participates in panel on pandemic preparedness at Forbes Healthcare Summit


Johns Hopkins Center for Health Security Director Tom Inglesby, MD, this week participated in a panel on pandemic preparedness at the 2024 Forbes Healthcare Summit in New York City. Moderated by Forbes Senior Editor Alex Knapp, the panel also featured Stéphane Bancel, CEO of Moderna, and Mariana Matus, PhD, cofounder and CEO of Biobot Analytics.


In a LinkedIn post, Inglesby summarized several key takeaways from the discussion, including that:

  • Ongoing viral threats demand continued pandemic preparedness and innovation;
  • Public-private partnerships are crucial for developing pandemic response tools; and
  • Healthcare systems need better preparedness strategies and clear crisis protocols before emergencies arise.


Read his full post here. 

Editor: Alyson Browett, MPH

Contributing Editor: Prarthana Vasudevan, MS, MSPH, DrPH (c)

Give Today
Click to Subscribe
 
X  Youtube  Linkedin